CEO sold ~$1.77M of Gilead Sciences
Scheduled in advanceLoading…
Planned for Sep 15, 2026 · Notice filed Sep 15, 2026
A top manager at Gilead Sciences told the SEC they plan to sell $433K of Gilead Sciences shares around Sep 15, 2026. The shares did not come from their pay.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
None found in footnotes
Only flagged when a footnote says so; never inferred
CEO sold ~$1.77M of Gilead Sciences
Scheduled in advanceCEO sold ~$446K of Gilead Sciences
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.